Mingling do's and don'ts

Linkedin, Facebook, MSN and Gmail are all perfect tools for the urban businessman or woman to keep track of and stay up-to-date with contacts. "But in the end, networking is about meeting and talking to people face-to-face," says mingling expert Mia Forsgren at Begriplig.

Cate Poulsen, Qiagen

Why are you going to Scanlab and Biotech Forum?

From planning stage to handshake

"Partnering is an effective tool to get in touch with the decision makers high up in an organization's administration," says Camilla Huse Bondeson at Conlega. And according to her, rigorous planning is the way to succeed.

Hey Johannes Hedman...

... graduate of SKL and LTH, who has improved a method of forensic analysis

Dry blood DNA storage on a matrix

Qiagen recently presented a method of dry blood sample storage as an alternative to storage in freezers.

Diagnostics to deal with new diseases

Maria Brytting at the Swedish Institute for Infectious Disease Control, SMI, will share her experiences from April 2009 when the new influenza A virus, H1N1, was first reported globally.

Reidar Rasmussen, Labmodul

Why are you going to Scanlab and Biotech Forum?

Age essential when testing drugs

Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established regulations stating that pharmaceuticals must be tested for children as well as for adults.

Annika Garnås, LAB

Why are you going to Scanlab+Biotech Forum?

Safe and economic dispensing of powders

Mettler Toledo is showcasing Quantos, an automated dispenser for laboratory use.

How to get the most out of the fair

Young, bright and committed to labtech

, becoming the new CEO of Swedish Labtech.

Life science in Stockholm

Sweden has the fourth-largest biotech market in Europe. More than half of its biotechnology enterprise, some 460 companies, is located in the Stockholm region.

Nya utmaningar för vaccinbolag

Sedan 2006 har den globala kapaciteten för att tillverka influensavaccin ökat från 400 miljoner doser per år till 900 miljoner. -Det här är ingen business as usual för vaccinbolagen, säger Albert Osterhaus, chef för institutionen för virologi på Rotterdams universitet.

With their hands on the legal levers

It is wonderful news for the Scandinavian scientific community. At the end of May it stood clear that Lund will host to the European Spallation Source.

The winner of the race

She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is focus according to Yvonne Mårtensson.

Kliniska prövningar satta på prov

Fas III-studier jämför ofta standardbehandlingar med nya alternativ. En ny studie visar att majoriteten inte är statistiskt hållbara.

Cellavision utser USA-chef

Blodanalysbolaget expanderar verksamheten i Nordamerika.

Cellavision mot Japan

Bolaget får sin första order via det japanska dotterbolaget i Yokohama.

Absorber säljer till USA

Två ledande amerikanska transplantationskliniker köper bolagets antikroppstest.

Major changes to the Q-Med board

The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.

Faster sales but less profits for Probi

The probiotic company increases its turnover, and the net results are twice as large as last year.

Swedish top scientists to EMBO

Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and one is from the University of Uppsala.

Re-painting the big pig-ture

Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.